Alto Neuroscience (ANRO) Treasury Shares (2023)
Alto Neuroscience (ANRO) posted Treasury Shares of $27000.0 for Q4 2025, little changed sequentially from $27000.0 in Q3 2025, and down 50.0% YoY from $54000.0 in Q4 2024.
Analysis
Alto Neuroscience (ANRO) Treasury Shares (2023) Analysis & Trends
Alto Neuroscience has reported Treasury Shares for 3 years, with the latest figure at $27000.0 in Q4 2025.
- Quarterly Treasury Shares fell 50.0% year-over-year to $27000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $27000.0 (down 50.0% YoY) and the FY2025 annual result came in at $27000.0, down 50.0% from the prior year.
- Treasury Shares was little changed at $27000.0 in Q4 2025 per ANRO's latest filing, from $27000.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $29.9 million in Q4 2023 and troughed at $27000.0 in Q3 2025.
- A 3-year average of $13.0 million and a median of $20.4 million in 2023 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2024 and 2025: Treasury Shares plunged 99.82% in 2024, then plunged 50.0% in 2025.
- Over 3 years, Treasury Shares stood at $29.9 million in 2023, then slumped by 99.82% to $54000.0 in 2024, then slumped by 50.0% to $27000.0 in 2025.
- According to Business Quant data, Treasury Shares over the past three periods registered $27000.0, $27000.0, and $54000.0 for Q4 2025, Q3 2025, and Q4 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 2.72 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Alto Neuroscience | 1.52 Bn | 1.52 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 29.92 Mn |
| Dec 31, 2023 | 29.92 Mn |
| Sep 30, 2023 | 20.37 Mn |
| Sep 30, 2023 | 20.37 Mn |
| Jun 30, 2023 | 20.37 Mn |
| Jun 30, 2023 | 20.37 Mn |
| Mar 31, 2023 | 20.37 Mn |
| Mar 31, 2023 | 20.37 Mn |